Positive results from Phase 3 ADAPT OCULUS study show VYVGART’s potential as the first targeted treatment for patients living with…
NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, Feb. 6, 2026 /PRNewswire/ -- The New York…
HANGZHOU, China, Dec. 16, 2025 /PRNewswire/ -- Jiuzi Holdings, Inc. (Nasdaq: JZXN) ("Jiuzi" or the "Company") today announced it is…
Achieves Milestone of Planting 100,000 Trees BENGALURU, India, June 5, 2025 /PRNewswire/ -- Marriott India proudly achieved its ambitious goal…